Financial Overview
|
(in million EUR) |
| |
FY ended Dec. 31, 2013 |
FY ended Dec. 31, 2012 |
Rate of change (%) |
Factors |
| Net Sales |
3,185.6 |
3,460.6 |
(7.9) |
1) |
| EBITDA |
297.0 |
274.2 |
8.3 |
- |
Factor1)
Net Sales-In 2013, the Company's consolidated sales decreased by 7.9% compared to 2012. The application of inflation accounting and valuation at the economic exchange rate for the activities in Venezuela from the beginning of 2013 impacted sales negatively. Other currency movements (mainly USD, CLP, INR and JPY) reinforced this decrease.
R&D Expenditure
|
(in million EUR) |
| |
FY ended Dec. 31, 2013 |
FY ended Dec. 31, 2012 |
| Total |
62.4 |
69.4 |
-In 2013, research and development expenses decreased by EUR 7 million to EUR 62 million as a result of cost savings actions. These R&D expenses related mainly to the activities of the international technology centers in Deerlijk (Belgium) and Jiangyin (China).
R&D Structure
-As of Dec. 31, 2013, the Company has 400 employees working in R&D on various projects worldwide.
-The Company's global technology platform consists of 2 main Technology Centers in Deerlijk (Belgium) and Jiangyin (Jiansu province, China).
